UBS MSCI Switzerland 20/35 UCITS ETF(hedged USD)A-acc is a equity ETF from UBS tracking the UBS Lux Fund Solutions – MSCI Switzerland 20/35 index through physical replication. Domiciled in Luxembourg and launched in 2020, the fund manages about 87 M € and charges a TER of 0.20% — 20 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
| Roche Holding AG | 14.0% |
| Novartis AG | 13.9% |
| Nestle S.A. | 12.8% |
| ABB Ltd | 8.2% |
| UBS Group AG | 7.6% |
| Compagnie Financière Richemont SA | 6.0% |
| Zurich Insurance Group AG | 5.4% |
| Lonza Group AG | 2.3% |
| Swiss Re AG | 2.3% |
| Holcim AG | 2.2% |
| SIX Swiss Exchange | CHUSD | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.